Dental Care Clinics in Hortonville, WI Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Otter Creek Dental, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 105 Kelly Way, Hortonville, WI 54944 Phone: 920-740-8706 |
Dr. Clint Dunathan Sc Smiles By Design Sc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 230 Towne Drive, Hortonville, WI 54944 Phone: 920-779-4533 Fax: 920-779-4333 |
Brothers In Bond, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 230 E Towne Dr, Hortonville, WI 54944 Phone: 920-779-4533 |
News Archive
NCI-PCPT explores survival of men on finasteride drug
In the NCI-sponsored Prostate Cancer Prevention Trial (PCPT), initial findings from a decade ago showed that the drug finasteride significantly reduced the risk of prostate cancer, but among those who did develop prostate cancer, paradoxically, the drug was associated with an increased risk of high-grade disease.
Smart ring can be reliably used to detect the onset of fevers
Temperature data collected by wearable devices worn on the finger can be reliably used to detect the onset of fevers, a leading symptom of both COVID-19 and the flu, according to a team of researchers from the University of California San Diego, UC San Francisco and MIT Lincoln Lab.
GOP claims Statehouse victories that could set back health law implementation
"The Democrats' ambitious health care overhaul is facing roadblocks from newly elected state officials who harshly criticized it while campaigning and who are now in a position to make good on their promises," Kaiser Health News reports. The GOP made significant political gains in Tuesday's election, taking "Governors' mansions in several states." Among the newly elected governors were Sam Brownback of Kansas, "who called the reform law 'an abomination,'" and Tennessee's Bill Haslam, who called the law "an 'intolerable expansion' of federal power."
Aeolus commences second study of AEOL 10150 against Acute Radiation Syndrome
Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) announced today the initiation of a second study, in mice, to determine the optimal length of treatment with AEOL 10150 when used as a countermeasure to Acute Radiation Syndrome (ARS) in the lungs. This study, led by Zeljko Vujaskovic, M.D. Ph.D. of Duke University, is designed to build on the recently completed study that demonstrated the efficacy of AEOL 10150 as a treatment for damage to the lungs due to exposure to radiation, and determine the most effective duration of delivery for treatment after exposure.
› Verified 3 days ago